The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Exosomes as Potent Cell-Free Peptide-Based Vaccine. II. Exosomes in CpG Adjuvants Efficiently Prime Naive Tc1 Lymphocytes Leading to Tumor Rejection
Abstract
Ideal vaccines should be stable, safe, molecularly defined, and out-of-shelf reagents efficient at triggering effector and memory Ag-specific T cell-based immune responses. Dendritic cell-derived exosomes could be considered as novel peptide-based vaccines because exosomes harbor a discrete set of proteins, bear functional MHC class I and II molecules that can be loaded with synthetic peptides of choice, and are stable reagents that were safely used in pioneering phase I studies. However, we showed in part I that exosomes are efficient to promote primary MHC class I-restricted effector CD8+ T cell responses only when transferred onto mature DC in vivo. In this work, we bring evidence that among the clinically available reagents, Toll-like receptor 3 and 9 ligands are elective adjuvants capable of triggering efficient MHC-restricted CD8+ T cell responses when combined to exosomes. Exosome immunogenicity across species allowed to verify the efficacy of good manufactory procedures-manufactured human exosomes admixed with CpG oligonucleotides in prophylactic and therapeutic settings of melanoma in HLA-A2 transgenic mice. CpG adjuvants appear to be ideal adjuvants for exosome-based cancer vaccines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dendritic cells and the control of immunity
Banchereau, J., & Steinman, R. M. (1998) · Nature · doi:10.1038/32588 · Cited by 14,336
Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3
Alexopoulou, L., Holt, A. C., Medzhitov, R., & Flavell, R. A. (2001) · Nature · doi:10.1038/35099560 · Cited by 6,129
A human homologue of the Drosophila Toll protein signals activation of adaptive immunity
Medzhitov, R., Preston-Hurlburt, P., & Janeway, C. A. (1997) · Nature · doi:10.1038/41131 · Cited by 5,590
Sallusto, F., & Lanzavecchia, A. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.179.4.1109 · Cited by 5,129
Tolerance, Danger, and the Extended Family
Matzinger, P. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.005015 · Cited by 4,820
Toll-like receptors: critical proteins linking innate and acquired immunity
Akira, S., Takeda, K., & Kaisho, T. (2001) · Nature Immunology · doi:10.1038/90609 · Cited by 4,777
The Dendritic Cell System and its Role in Immunogenicity
Steinman, R. M. (1991) · Annual Review of Immunology · doi:10.1146/annurev.iy.09.040191.001415 · Cited by 4,658
B lymphocytes secrete antigen-presenting vesicles.
Raposo, G., Nijman, H. W., Stoorvogel, W., Liejendekker, R., Harding, C. V., Melief, C. J., & Geuze, H. J. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.3.1161 · Cited by 3,546
CpG motifs in bacterial DNA trigger direct B-cell activation
Krieg, A. M., Yi, A.-K., Matson, S., Waldschmidt, T. J., Bishop, G. A., Teasdale, R., Koretzky, G. A., & Klinman, D. M. (1995) · Nature · doi:10.1038/374546a0 · Cited by 3,508
Approaching the Asymptote? Evolution and Revolution in Immunology
Janeway, C. A. (1989) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1989.054.01.003 · Cited by 3,252
A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell
Ridge, J. P., Di Rosa, F., & Matzinger, P. (1998) · Nature · doi:10.1038/30989 · Cited by 2,342
Zitvogel, L., Regnault, A., Lozier, A., Wolfers, J., Flament, C., Tenza, D., Ricciardi-Castagnoli, P., Raposo, G., & Amigorena, S. (1998) · Nature Medicine · doi:10.1038/nm0598-594 · Cited by 2,266
Self-citationCella, M., Scheidegger, D., Palmer-Lehmann, K., Lane, P., Lanzavecchia, A., & Alber, G. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.2.747 · Cited by 1,983
The immune system evolved to discriminate infectious nonself from noninfectious self
Janeway, C. A. (1992) · Immunology Today · doi:10.1016/0167-5699(92)90198-g · Cited by 1,342
Activation of human dendritic cells through CD40 cross-linking.
Caux, C., Massacrier, C., Vanbervliet, B., Dubois, B., Van Kooten, C., Durand, I., & Banchereau, J. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.4.1263 · Cited by 1,317
Fernandez, N. C., Lozier, A., Flament, C., Ricciardi-Castagnoli, P., Bellet, D., Suter, M., Perricaudet, M., Tursz, T., Maraskovsky, E., & Zitvogel, L. (1999) · Nature Medicine · doi:10.1038/7403 · Cited by 1,060
Self-citationMuzio, M., Bosisio, D., Polentarutti, N., D’amico, G., Stoppacciaro, A., Mancinelli, R., van’t Veer, C., Penton-Rol, G., Ruco, L. P., Allavena, P., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.11.5998 · Cited by 1,060
CpG Oligodeoxynucleotides Act as Adjuvants that Switch on T Helper 1 (Th1) Immunity
Chu, R. S., Targoni, O. S., Krieg, A. M., Lehmann, P. V., & Harding, C. V. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.10.1623 · Cited by 1,002
Sparwasser, T., Koch, E.-S., Vabulas, R. M., Heeg, K., Lipford, G. B., Ellwart, J. W., & Wagner, H. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199806)28:06<2045::aid-immu2045>3.0.co;2-8 · Cited by 794
Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo.
De Smedt, T., Pajak, B., Muraille, E., Lespagnard, L., Heinen, E., De Baetselier, P., Urbain, J., Leo, O., & Moser, M. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.4.1413 · Cited by 762
Production and characterization of clinical grade exosomes derived from dendritic cells
Lamparski, H. G., Metha-Damani, A., Yao, J.-Y., Patel, S., Hsu, D.-H., Ruegg, C., & Le Pecq, J.-B. (2002) · Journal of Immunological Methods · doi:10.1016/s0022-1759(02)00330-7 · Cited by 700
Adjuvants — a balance between toxicity and adjuvanticity
Gupta, R. K., Relyveld, E. H., Lindblad, E. B., Bizzini, B., Ben-Efraim, S., & Gupta, C. K. (1993) · Vaccine · doi:10.1016/0264-410x(93)90190-9 · Cited by 545
Type I interferons produced by dendritic cells promote their phenotypic and functional activation
Montoya, M., Schiavoni, G., Mattei, F., Gresser, I., Belardelli, F., Borrow, P., & Tough, D. F. (2002) · Blood · doi:10.1182/blood.v99.9.3263 · Cited by 534
André, F., Chaput, N., Schartz, N. E. C., Flament, C., Aubert, N., Bernard, J., Lemonnier, F., Raposo, G., Escudier, B., Hsu, D.-H., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.4.2126 · Cited by 496
Self-citationZinkernagel, R. M., Ehl, S., Aichele, P., Oehen, S., Kündig, T., & Hengartner, H. (1997) · Immunological Reviews · doi:10.1111/j.1600-065x.1997.tb00969.x · Cited by 489
Häcker, H., Vabulas, R. M., Takeuchi, O., Hoshino, K., Akira, S., & Wagner, H. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.4.595 · Cited by 468
Roake, J. A., Rao, A. S., Morris, P. J., Larsen, C. P., Hankins, D. F., & Austyn, J. M. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.6.2237 · Cited by 464
McWilliam, A. S., Napoli, S., Marsh, A. M., Pemper, F. L., Nelson, D. J., Pimm, C. L., Stumbles, P. A., Wells, T. N. C., & Holt, P. G. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.184.6.2429 · Cited by 328
Bacterial CpG DNA Activates Immune Cells to Signal Infectious Danger
Wagner, H. (1999) · Advances in Immunology · doi:10.1016/s0065-2776(08)60790-7 · Cited by 314
Bacterial CpG-DNA Triggers Activation and Maturation of Human CD11c−, CD123+ Dendritic Cells
Bauer, M., Redecke, V., Ellwart, J. W., Scherer, B., Kremer, J.-P., Wagner, H., & Lipford, G. B. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.8.5000 · Cited by 293
Kadowaki, N., Antonenko, S., & Liu, Y.-J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.4.2291 · Cited by 280
Kirn, J. J., Bagarazzi, M. L., Trivedi, N., Hu, Y., Kazahaya, K., Wilson, D. M., Ciccarelli, R., Chattergoon, M. A., Dang, K., Mahalingam, S., et al. (1997) · Nature Biotechnology · doi:10.1038/nbt0797-641 · Cited by 219
Proietti, E., Bracci, L., Puzelli, S., Di Pucchio, T., Sestili, P., De Vincenzi, E., Venditti, M., Capone, I., Seif, I., De Maeyer, E., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.1.375 · Cited by 218
Heckelsmiller, K., Rall, K., Beck, S., Schlamp, A., Seiderer, J., Jahrsdörfer, B., Krug, A., Rothenfusser, S., Endres, S., & Hartmann, G. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.7.3892 · Cited by 194
Dendritic Cells Internalize Vaccine Adjuvant after Intramuscular Injection
Dupuis, M., Murphy, T. J., Higgins, D., Ugozzoli, M., van Nest, G., Ott, G., & McDonald, D. M. (1998) · Cellular Immunology · doi:10.1006/cimm.1998.1283 · Cited by 185
Immunostimulatory CpG-Oligodeoxynucleotides Cause Extramedullary Murine Hemopoiesis
Sparwasser, T. D., Hültner, L., Koch, E. S., Luz, A., Lipford, G. B., & Wagner, H. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.4.2368 · Cited by 147
Immunogenecity signals 1,2,3... and 0
Janeway, C. A. (1989) · Immunology Today · doi:10.1016/0167-5699(89)90081-9 · Cited by 140
Lipford, G. B., Sparwasser, T. D., Zimmermann, S., Heeg, K. M., & Wagner, H. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.3.1228 · Cited by 138
Causing a commotion in the blood: immunotherapy progresses from bacteria to bacterial DNA
Krieg, A. Μ., & Wagner, H. (2000) · Immunology Today · doi:10.1016/s0167-5699(00)01719-9 · Cited by 132
Vabulas, R. M., Pircher, H., Lipford, G. B., Häcker, H., & Wagner, H. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.5.2372 · Cited by 123
Mechanism of Action of CpG DNA
KRIEG, A. M., Hartmann, G., & Yi, A. (2000) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-59672-8_1 · Cited by 116
Immunological tolerance: Danger – pathogen on the premises!
Janeway, C. A., Goodnow, C. C., & Medzhitov, R. M. (1996) · Current Biology · doi:10.1016/s0960-9822(02)00531-6 · Cited by 89
Dendritic Cell Maturation Overrules H-2d–Mediated Natural Killer T (Nkt) Cell Inhibition
Ikarashi, Y., Mikami, R., Bendelac, A. S., Terme, M., Chaput, N., Terada, M., Tursz, T., Angevin, E., Lemonnier, F. A., Wakasugi, H., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.8.1179 · Cited by 74
Self-citationOstler, T., & Ehl, S. R. (2002) · Journal of Immunological Methods · doi:10.1016/s0022-1759(02)00191-6 · Cited by 68
IL-2 mediates adjuvant effect of dendritic cells
Granucci, F., Andrews, D. M., Degli-Esposti, M. A., & Ricciardi‐Castagnoli, P. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02187-7 · Cited by 57
Suhadolnik, R. J., Reichenbach, N. L., Hitzges, P., Adelson, M. E., Peterson, D. L., Cheney, P. R., Salvato, P., Thompson, C., Loveless, M. O., & Müller, W. E. G. (1994) · PubMed · Cited by 54
Lascelles, A., Eagleson, G. K., BEH, K. J., & Watson, D. L. (1989) · Veterinary Immunology and Immunopathology · doi:10.1016/0165-2427(89)90160-8 · Cited by 31
Li, D., Ronson, B. B., Guo, M., Liu, S., Bishop, J. S., Echo, D. A. V., & O'Malley, B. W. (2002) · PubMed · Cited by 24
Bahr, G. M., Pouillart, P., & CHEDID, L. A. (1996) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.1996.16.297 · Cited by 16
Dendritic Cells: Nature’s Adjuvants
Austyn, J. M. (1993) · Springer eBooks · doi:10.1007/978-1-4615-2948-4_1 · Cited by 11
Cited by
Membrane vesicles as conveyors of immune responses
Théry, C., Ostrowski, M., & Segura, E. (2009) · Nature Reviews Immunology · doi:10.1038/nri2567 · Cited by 3,882
Classification, Functions, and Clinical Relevance of Extracellular Vesicles
van der Pol, E., Böing, A. N., Harrison, P., Sturk, A., & Nieuwland, R. (2012) · Pharmacological Reviews · doi:10.1124/pr.112.005983 · Cited by 1,754
Applying extracellular vesicles based therapeutics in clinical trials – an ISEV position paper
Lener, T., Gimona, M., Aigner, L., Börger, V., Buzas, E., Camussi, G., Chaput, N., Chatterjee, D., Court, F. A., del Portillo, H. A., et al. (2015) · Journal of Extracellular Vesicles · doi:10.3402/jev.v4.30087 · Cited by 1,491
Self-citationEscudier, B., Dorval, T., Chaput, N., André, F., Caby, M.-P., Novault, S., Flament, C., Leboulaire, C., Borg, C., Amigorena, S., et al. (2005) · Journal of Translational Medicine · doi:10.1186/1479-5876-3-10 · Cited by 1,280
Self-citationExosomes in cancer development, metastasis, and drug resistance: a comprehensive review
Azmi, A. S., Bao, B., & Sarkar, F. H. (2013) · Cancer and Metastasis Reviews · doi:10.1007/s10555-013-9441-9 · Cited by 1,167
Metadata
- Authors
- Chaput, N., Schartz, N. E. C., André, F., Taïeb, J., Novault, S., Bonnaventure, P., Aubert, N., Bernard, J., Lemonnier, F., Merad, M., Adema, G., Adams, M., Ferrantini, M., Carpentier, A. F., Escudier, B., Tursz, T., Angevin, E., & Zitvogel, L.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-02
- Volume
- 172
- Issue
- 4
- Pages
- 2137-2146
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1838162521
- Cited by
- 266
- References
- 50
- FWCI
- 6.56
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.